Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.

Journal of hypertension - 1 Oct 2010

Irvin Marguerite R, Lynch Amy I, Kabagambe Edmond K, Tiwari Hemant K, Barzilay Joshua I, Eckfeldt John H, Boerwinkle Eric, Davis Barry R, Ford Charles E, Arnett Donna K

Abstract excerpt

BACKGROUND: Several clinical studies report increased risk of diabetes mellitus with pharmacologic treatment for hypertension (HTN). HTN genes may modify glycemic response to antihypertensive treatment. METHOD: The current study examined the association of 24 single nucleotide polymorphisms (SNPs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Antihypertensive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium Channel Blockers

Share to Diabetes Mellitus

Share to Diuretics

Share to Double-Blind Method

Share to Epithelial Sodium Channels

Share to Fasting

Source

Open in PubMed Open full text

Identifiers

PMID: 20577119
DOI: 10.1097/HJH.0b013e32833c7a4d
PMCID: PMC2957368

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20577119-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.PMID 20577119Read ↗

PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.Semantic proximity Read ↗

Assessment of genetic and clinical factors in T2D susceptibility among patients with hypertension.Semantic proximity Read ↗

The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.Semantic proximity Read ↗

Genetic polymorphisms in diabetes: influence on therapy with oral antidiabetics.Semantic proximity Read ↗

Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.Semantic proximity Read ↗

Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals.Semantic proximity Read ↗

A Polygenic Score for Type 2 Diabetes Risk Is Associated With Both the Acute and Sustained Response to Sulfonylureas.Semantic proximity Read ↗

Pharmacogenetics of antihypertensive treatment.Semantic proximity Read ↗

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.Semantic proximity Read ↗

The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.Semantic proximity Read ↗

Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic RiskSemantic proximity Read ↗

Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.